← All Syros Pharmaceuticals, INC filings

Syros Pharmaceuticals, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

OTC.Pink
SYRS
Syros Pharmaceuticals, INC
SCHEDULE 13D/A: Samsara BioCapital Reduces Stake in Syros Pharmaceuticals Below 5% Threshold
Samsara BioCapital and its affiliates have significantly reduced their beneficial ownership in Syros Pharmaceuticals, Inc., falling below the 5% threshold due to recent open market sales.